50 reports

Also, ## in ## people in Japan lives with diabetes-related distress.

  • Chronic Pain
  • World
  • Forecast
  • Market Size
  • Zimmer Biomet Holdings, Inc.

Middle East & Africa ##.

  • Chronic Pain
  • World
  • Market Size
  • bioMerieux S.A.
  • Roche Group
  • 4 Disease Overview

-T. et al. (2010) ' Inhibition of the expression and function of TRPV## by RNA interference in dorsal root ganglion', Neurological Research, ##(##), pp. ##-##. doi: ##. ##/ ##X##.

  • Chronic Pain
  • United States
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.

It is principally engaged in the development of RNA-based biomarkers and companion diagnostics.

  • Chronic Pain
  • Market Size
  • Beckman Coulter, Inc.
  • F. Hoffmann-La Roche Ltd.
  • SQI Diagnostics Inc.

IT AFFECTS ## IN ##, ## TO ## IN ##, ## BIRTHS.

  • Chronic Pain
  • Clinical Trial
  • Hospital
  • Mental Health
  • AutoGenomics, Inc.

The combined company has a focused pipeline of TGF-beta RNA Therapeutics for late stage cancers, including gliomas, pancreatic cancer and melanoma.

  • Chronic Pain
  • United States
  • World
  • Product Initiative
  • Medivir UK Ltd.

Patients were randomized to one of five treatment groups in a ##:##:##:##:## fashion: fasinumab ##mg, ##mg, ##mg, ##mg, or placebo, all delivered subcutaneously every ## weeks through week ##, with the primary efficacy measured at week ##.

  • Arthritis
  • Chronic Pain
  • World
  • Product Initiative
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • World
  • Target

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • World
  • Pain Therapeutics

The composition of CS contains the following components: (##) Thymosin, (##) Immune RNA, (##) Astragalus polysaccharide, (##) Transfer factor, (##) Utilins, (##) Polysaccharide of BCG, (##) Letinous Other Developmental Activities edodes polysaccharide and (##) Manose polysaccharides-peptid

  • Chronic Pain
  • United States
  • World
  • Product Initiative
  • Aptinyx Inc.

Sylentis SAU (Sylentis), a subsidiary of Pharma Mar SA is a biotechnology company that researches and develops new medicaments based on RNA interference gene silencing technology.

  • Chronic Pain
  • Research And Development
  • Therapy
  • United States
  • Flex Pharma, Inc.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • Pharmaceutical
  • World

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • World

It targets JAK ##.

  • Chronic Pain
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Galapagos NV

one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Biomarker
  • Chronic Disease
  • Chronic Pain
  • Immunodiagnostics
  • Firalis SAS
  • AS-001 - DRUG PROFILE
  • ANTISENSE OLIGONUCLEOTIDE FOR OSTEOARTHRITIS - DRUG PROFILE

AS-## IS A NOVEL ANTI-ARTHRITIC SMALL INTERFERING RNA (SIRNA).

  • Arthritis
  • Chronic Pain
  • Therapy
  • United States
  • Can-Fite BioPharma Ltd.

SR One Ltd.

  • Chronic Pain
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Regeneron Pharmaceuticals, Inc.
  • ISOLATERHEUM - PRODUCT DESCRIPTION
  • RADX - PRODUCT DESCRIPTION

DxTerity' s dxdirect technology facilitates the direct blood testing of RNA and DNA.

  • Arthritis
  • Biomarker
  • Chronic Pain
  • Clinical Trial
  • Beckman Coulter, Inc.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Drug Development
  • World
  • Pfizer Inc.

##, Prostaglandin G/ H Synthase ## Transient Receptor Potential Cation Channel Subfamily V Member ## Small Molecule Small Molecule Phase I Monoclonal Antibody Cytokine and growth factor receptors Phase I Small Molecule Phase I NovImmune SA Phase I Toll Like Receptor ## Undisclosed

  • Chronic Pain
  • Medical Biotechnology
  • Monoclonal Antibody
  • Pharmaceutical
  • Protein Therapy

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • World
  • Product Initiative
  • Pfizer Inc.
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Hospital
  • Opioid
  • Pain Therapeutics
  • RNAI GENE THERAPY TO BLOCK NAV1.7 FOR NEUROPATHIC PAIN - DRUG PROFILE
  • NEUROPATHIC PAIN - PIPELINE BY NOVARTIS AG, H1 2018

Neuropathic Pain - Overview Neuropathic Pain - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR NEUROPATHIC PAIN, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR NEUROPATHIC PAIN, H## 2018 Pre-Registration ## ## Phase III ## ## Phase II ## ## Phase I ## ## Precl

  • Chronic Pain
  • Neurological Disorder
  • Pharmaceutical
  • Therapy
  • Can-Fite BioPharma Ltd.
  • AS-001 - DRUG PROFILE
  • OSTEOARTHRITIS - PIPELINE BY LG CHEM LTD, H2 2018

AS-## IS A NOVEL ANTI-ARTHRITIC SMALL INTERFERING RNA (SIRNA).

  • Chronic Pain
  • United States
  • World
  • Company
  • Product Initiative
  • MAR 13, 2017: BRISTOL-MYERS SQUIBB'S ORENCIA REJECTS FOR USE WITHIN NHS SCOTLAND

CST. ## RA.

  • Arthritis
  • Chronic Pain
  • Immunotherapy
  • Therapy
  • Bristol-Myers Squibb Company
  • VISCERAL PAIN - PIPELINE BY GRUNENTHAL GMBH, H2 2018
  • VISCERAL PAIN - PIPELINE BY ELI LILLY AND CO, H2 2018

The novel mechanism of action of ##GA leads to excision of the targeted RNA in the central region.

  • Chronic Pain
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

The molecules developed by companies in Phase III, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Arthritis
  • Chronic Pain
  • United States
  • Product Initiative
  • Samumed, LLC
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Opioid
  • World
  • Pfizer Inc.
  • VISCERAL PAIN - PIPELINE BY IDERA PHARMACEUTICALS INC
  • VISCERAL PAIN - PIPELINE BY GRUNENTHAL GMBH

FOCUSES ON THE DISCOVERY AND DEVELOPMENT OF RNA-TARGETED DRUGS.

  • Chronic Pain
  • Pharmaceutical
  • Company
  • Product Initiative
  • Pfizer Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Drug Development
  • Neurology
  • Pfizer Inc.